C. Merrifield

C.
Ann Merrifield is currently Chairman at InVivo Therapeutics Corp., Vice Chairman at The Spaulding Rehabilitation Hospital Corp., Director at Partners HealthCare Corp., Independent Director at Lyra Therapeutics, Inc. since 2019, Director at Veritas Genetics International Ltd., Director at Spaulding Nursing & Therapy Center Brighton, Inc., Trustee at MassMutual Premier Funds, Trustee at MML Series Investment Fund II, Trustee at Huntington Theatre Co., Trustee at Young Men's Christian Association of Greater Boston, Inc., Trustee at Spaulding Rehabilitation, Inc., and Trustee at Partners HealthCare at Home, Inc. Former roles include President, Chief Executive Officer & Director at PathoGenetix, Inc. from 2012 to 2014; Independent Director at Catalent JNP, Inc. from 2015 to 2018; Independent Director at Flexion Therapeutics, Inc. from 2014 to 2021; Director at Veritas Genetics, Inc. from 2016 to 2019; Lead Director at Invivo Therapeutics Holdings Corp.
from 2015 to 2017; SVP & President-Genzyme Biosurgery at Genzyme Corp.
from 2009 to 2011; Partner at Bain & Co., Inc. from 1987 to 1992; President at Genzyme Biosurgery Corp.; President at Genzyme Genetics, Inc.; and Investment Officer at Aetna Life & Casualty Co. Education includes undergraduate and graduate degrees from the University of Maine and an MBA from the Tuck School of Business at Dartmouth.